Chondrogenic Differentiation of MSCs

NF Niamh Fahy
VC Virginia Palomares Cabeza
AL Andrea Lolli
JW Janneke Witte-Bouma
AM Ana Merino
YR Yanto Ridwan
EW Eppo B. Wolvius
MH Martin J. Hoogduijn
EF Eric Farrell
PB Pieter A. J. Brama
request Request a Protocol
ask Ask a question
Favorite

For chondrogenic differentiation, 2 × 105 MSCs were suspended in 500 µl of chondrogenic differentiation medium composed of high glucose Dulbecco’s Modified Eagle Medium supplemented with 1.5 µg/ml fungizone, 50 µg/ml gentamicin, 1 mM sodium pyruvate (All Thermo Fisher Scientific), 1% v/v Insulin-Transferrin-Selenous acid (ITS™+ Premix, Corning, Bedford, MA, USA), 40 µg/ml proline (Sigma-Aldrich), 25 µg/ml L-ascorbic acid 2-phosphate, 100 nM Dexamethasone (Sigma-Aldrich), and 10 ng/ml transforming growth factor-β3 (R&D systems, Minneapolis, MN, USA). The cell suspension was added to 15 ml conical polypropylene tubes (VWR, Radnor, PA, USA) and centrifuged at 300 g for 8 min to facilitate pellet formation. Chondrogenic MSC pellets were cultured at 37°C and 5% carbon dioxide in a humidified atmosphere, and culture medium was refreshed every 3–4 days for 21 days. Chondrogenic differentiation of MSCs in vitro following 21 days of culture was confirmed histologically by thionine staining ( Supplementary Figure S1 ).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A